|
CWC27 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62581059726108E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.03721542044877E-14 |
| Normal-vs-Stage2 |
1.3978000001913E-07 |
| Normal-vs-Stage3 |
2.41384690014002E-12 |
| Normal-vs-Stage4 |
1.66733293838206E-12 |
| Stage1-vs-Stage2 |
4.612800E-01 |
| Stage1-vs-Stage3 |
2.785000E-01 |
| Stage1-vs-Stage4 |
5.554500E-02 |
| Stage2-vs-Stage3 |
1.835190E-01 |
| Stage2-vs-Stage4 |
4.828400E-02 |
| Stage3-vs-Stage4 |
4.444000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.33066907387547E-15 |
| Normal-vs-AfricanAmerican |
9.92779999999804E-05 |
| Normal-vs-Asian |
7.29969995560964E-09 |
| Caucasian-vs-AfricanAmerican |
1.528820E-01 |
| Caucasian-vs-Asian |
5.742600E-01 |
| AfricanAmerican-vs-Asian |
3.763600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.75415237890775E-14 |
| Normal-vs-Female |
1.66022751102446E-12 |
| Male-vs-Female |
2.241200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.11020090290504E-12 |
| Normal-vs-Age(41-60Yrs) |
7.57283125096819E-13 |
| Normal-vs-Age(61-80Yrs) |
1.89570581454745E-12 |
| Normal-vs-Age(81-100Yrs) |
2.982700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.236200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.049400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.216800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.104600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.789800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.341200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.776300E-02 |
| Classical-VS-Follicular |
1.526420E-01 |
| Classical-VS-Other |
1.380790E-01 |
| Classical-VS-Normal |
2.01627603502175E-12 |
| Tall-VS-Follicular |
4.150800E-01 |
| Tall-VS-Other |
7.063600E-01 |
| Tall-VS-Normal |
3.52670004311051E-10 |
| Follicular-VS-Other |
4.400800E-01 |
| Follicular-VS-Normal |
1.62429958372456E-10 |
| Other-VS-Normal |
8.33310000000198E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.69375624636814E-12 |
| Normal-vs-N1 |
4.59632332194815E-14 |
| N0-vs-N1 |
4.139600E-02 |
|
|
